Tag: Intas Pharmaceuticals

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Intas Pharmaceuticals

Covid-19 pandemic: Plasma therapy gets thumbs down from expert panel

Added to Collection on: 2021-02-17 18:33:45

Tags for this article:

Branches of biology
Health sciences
Medicine
Food and Drug Administration
Blood products
Transfusion medicine
Antibodies
Glycoproteins
Hyperimmune globulin
Coronavirus disease
Blood plasma
Emergency use authorization
Intas Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Taiwan, India ink pharma collaboration worth $217M

Added to Collection on: 2021-03-05 17:15:00

Tags for this article:

Companies based in Ahmedabad
Intas Biopharmaceuticals
foresee pharmaceuticals
United States
Intas Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Biopharma Security and China - AAF - The American Action Forum

Added to Collection on: 2024-06-10 20:06:21

Tags for this article:

Pharmaceuticals policy
Pharmaceutical industry of Gujarat
Healthcare in India
Food and Drug Administration
Intas Pharmaceuticals
Center for Drug Evaluation and Research
Pharmaceutical industry in India
Pharmaceutical industry in China
Generic drug
Pharmaceutical industry
John Walker

Click the tags to see associated articles and topics

View Article Details
Biosimilar Monoclonal Antibodies Market Booming Biosimilar - openPR.com

Added to Collection on: 2024-06-18 23:57:28

Tags for this article:

Orphan drugs
Monoclonal antibodies
Specialty drugs
Immunosuppressants
Immunology
Biosimilar
Adalimumab
Biopharmaceutical
Infliximab
Trastuzumab
Intas Pharmaceuticals
Biocon
Denosumab
Cetuximab
Ranibizumab
Bevacizumab
Eculizumab
Rituximab

Click the tags to see associated articles and topics

View Article Details
FDA Approves Imuldosa, a Biosimilar to Stelara

Added to Collection on: 2024-10-11 20:40:21

Tags for this article:

Autoimmune diseases
Monoclonal antibodies
Immunosuppressants
Biotechnology
Psoriasis
Ustekinumab
Biopharmaceutical
Biosimilar
Amgen
Intas Pharmaceuticals
Psoriatic arthritis
Ulcerative colitis
United States

Click the tags to see associated articles and topics

View Article Details
Leading Element Driving Change in the Biosimilar Lymphocyte Modulator Market in 2025

Added to Collection on: 2025-02-20 15:49:55

Tags for this article:

Clusters of differentiation
Immunosuppressants
Specialty drugs
Biopharmaceuticals
Biosimilar
Biotechnology
Sandoz
Glenmark Pharmaceuticals
Intas Pharmaceuticals
Biocon
Novartis
Efalizumab

Click the tags to see associated articles and topics

View Article Details
Accord BioPharma, Inc. Announces Completion of UDENYCA® (pegfilgrastim-cbqv ...

Added to Collection on: 2025-04-15 15:49:50

Tags for this article:

Amgen
Recombinant proteins
Pegfilgrastim
Intas Pharmaceuticals
Biosimilar
Filgrastim
Accord
Biopharmaceutical
Pharmaceutical industry in India
Ranibizumab
Intas Pharmaceuticals, Ltd.
Accord BioPharma
United States
Accord BioPharma Inc.

Click the tags to see associated articles and topics

View Article Details
Bio-Thera Solutions Announces FDA Accepts Biologics License Application for BAT2506, a ...

Added to Collection on: 2025-07-16 18:01:32

Tags for this article:

Monoclonal antibodies
Orphan drugs
Immunosuppressants
Disease-modifying antirheumatic drugs
Specialty drugs
Golimumab
Biopharmaceutical
Biosimilar
Adalimumab
Intas Pharmaceuticals
Bevacizumab
Ustekinumab
Bio-Thera Solutions
Thera Solutions, Ltd.
United States

Click the tags to see associated articles and topics

View Article Details
Intas Pharmaceuticals, Accord BioPharma acquires UDENYCA - IndiaMedToday

Added to Collection on: 2025-08-08 18:31:11

Tags for this article:

Recombinant proteins
Pegfilgrastim
Intas Pharmaceuticals
Biosimilar
Filgrastim
Accord
Neulasta
Coherus Biosciences Inc.
United States

Click the tags to see associated articles and topics

View Article Details
Book a Demo